跳至主要内容
临床试验/ACTRN12607000307404
ACTRN12607000307404招募中2 期

A randomised phase II study of PSA (prostate specific antigen) response and safety of two dose schedules of PI-88 in combination with docetaxel in patients with androgen-independent prostate cancer

未提供0 个研究点目标入组 82 人开始时间: 2005年7月6日最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
未提供

相似试验

进行中(未招募)
2 期
A study to investigate whether a combined Positron emission tomography (PET) and computerised tomography (CT) scan which utilises a tracer called Prostate Specific Membrane Antigen (PSMA) - a substance expressed by prostate cancer cells - can be used to better identify locally recurrent prostate cancer in men with a rising Prostate Specific Antigen (PSA) following radical prostatectomy. The study will then measure the impact of early salvage radiation therapy using advanced localisation techniques on patient survival, clinical toxicity, health related quality of life and prostate cancer-specific quality of life.Recurrent prostate cancerCancer - Prostate
ACTRN12615001183572Icon Cancer Foundation110
终止
2 期
Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate CancerProstate CancerProstatic Neoplasms
NCT02362451National Cancer Institute (NCI)7
已完成
4 期
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)Prostatic Neoplasms
NCT04108208Janssen Research & Development, LLC75
进行中(未招募)
2 期
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following SurgeryProstate Cancer
NCT03809000RTOG Foundation, Inc.188
招募中
2 期
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate CancerProstate Cancer
NCT04402151Weill Medical College of Cornell University50